Argenica Therapeutics Ltd

Research Argenica Therapeutics Ltd (AGN) on Bullrun: market cap AUD 12.33M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAGN
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 12.33M
• Financial periodFY2025
• Net income-AUD 7.17M
• Free cash flow-AUD 5.70M

Valuation Snapshot

latest market cap is AUD 12.33M.

About Argenica Therapeutics Ltd

Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.

Frequently asked questions

What is Argenica Therapeutics Ltd's market cap?

Argenica Therapeutics Ltd's market capitalization is AUD 12.33M.

What does Argenica Therapeutics Ltd do?

Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia.